164 related articles for article (PubMed ID: 31968628)
21. Structural requirements of flavonoids for increment of ocular blood flow in the rabbit and retinal function recovery in rat eyes.
Park YH; Xu XR; Chiou GC
J Ocul Pharmacol Ther; 2004 Jun; 20(3):189-200. PubMed ID: 15279724
[TBL] [Abstract][Full Text] [Related]
22. Comparative Study of Dietary Flavonoids with Different Structures as α-Glucosidase Inhibitors and Insulin Sensitizers.
Jia Y; Ma Y; Cheng G; Zhang Y; Cai S
J Agric Food Chem; 2019 Sep; 67(37):10521-10533. PubMed ID: 31461284
[TBL] [Abstract][Full Text] [Related]
23. Natural flavonoid α-glucosidase inhibitors from Retama raetam: Enzyme inhibition and molecular docking reveal important interactions with the enzyme active site.
Ghani U; Nur-E-Alam M; Yousaf M; Ul-Haq Z; Noman OM; Al-Rehaily AJ
Bioorg Chem; 2019 Jun; 87():736-742. PubMed ID: 30954838
[TBL] [Abstract][Full Text] [Related]
24. Natural constituents of St. John's Wort inhibit the proteolytic activity of human thrombin.
Wei LH; Chen TR; Fang HB; Jin Q; Zhang SJ; Hou J; Yu Y; Dou TY; Cao YF; Guo WZ; Ge GB
Int J Biol Macromol; 2019 Aug; 134():622-630. PubMed ID: 31047931
[TBL] [Abstract][Full Text] [Related]
25. Development of novel HER2 inhibitors against gastric cancer derived from flavonoid source of
Babu TM; Rammohan A; Baki VB; Devi S; Gunasekar D; Rajendra W
Drug Des Devel Ther; 2016; 10():3611-3632. PubMed ID: 27853354
[TBL] [Abstract][Full Text] [Related]
26. Molecular docking and dynamics simulation study of flavonoids as BET bromodomain inhibitors.
Raj U; Kumar H; Varadwaj PK
J Biomol Struct Dyn; 2017 Aug; 35(11):2351-2362. PubMed ID: 27494802
[TBL] [Abstract][Full Text] [Related]
27. The study of inhibitory effect of natural flavonoids toward β-glucuronidase and interaction of flavonoids with β-glucuronidase.
Sun CP; Yan JK; Yi J; Zhang XY; Yu ZL; Huo XK; Liang JH; Ning J; Feng L; Wang C; Zhang BJ; Tian XG; Zhang L; Ma X
Int J Biol Macromol; 2020 Jan; 143():349-358. PubMed ID: 31830453
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of angiotensin-converting enzyme activity by flavonoids: structure-activity relationship studies.
Guerrero L; Castillo J; Quiñones M; Garcia-Vallvé S; Arola L; Pujadas G; Muguerza B
PLoS One; 2012; 7(11):e49493. PubMed ID: 23185345
[TBL] [Abstract][Full Text] [Related]
29. 3D-QSAR and docking studies of flavonoids as potent Escherichia coli inhibitors.
Fang Y; Lu Y; Zang X; Wu T; Qi X; Pan S; Xu X
Sci Rep; 2016 Apr; 6():23634. PubMed ID: 27049530
[TBL] [Abstract][Full Text] [Related]
30. Design, synthesis, and anti-thrombotic evaluation of some novel fluorinated thrombin inhibitor derivatives.
Chen H; Ren Y
Arch Pharm (Weinheim); 2015 Jun; 348(6):408-20. PubMed ID: 25881141
[TBL] [Abstract][Full Text] [Related]
31. Structure-activity relationships of flavonoids as natural inhibitors against E. coli β-glucuronidase.
Weng ZM; Wang P; Ge GB; Dai ZR; Wu DC; Zou LW; Dou TY; Zhang TY; Yang L; Hou J
Food Chem Toxicol; 2017 Nov; 109(Pt 2):975-983. PubMed ID: 28347758
[TBL] [Abstract][Full Text] [Related]
32. Flavonoids as human carboxylesterase 2 inhibitors: Inhibition potentials and molecular docking simulations.
Song SS; Sun CP; Zhou JJ; Chu L
Int J Biol Macromol; 2019 Jun; 131():201-208. PubMed ID: 30872054
[TBL] [Abstract][Full Text] [Related]
33. Design, Synthesis and Molecular Docking Analysis of Flavonoid Derivatives as Potential Telomerase Inhibitors.
Fan ZF; Ho ST; Wen R; Fu Y; Zhang L; Wang J; Hu C; Shaw PC; Liu Y; Cheng MS
Molecules; 2019 Sep; 24(17):. PubMed ID: 31480619
[TBL] [Abstract][Full Text] [Related]
34. Structure⁻Activity Relationship and Molecular Docking of Natural Product Library Reveal Chrysin as a Novel Dipeptidyl Peptidase-4 (DPP-4) Inhibitor: An Integrated In Silico and In Vitro Study.
Kalhotra P; Chittepu VCSR; Osorio-Revilla G; Gallardo-Velázquez T
Molecules; 2018 Jun; 23(6):. PubMed ID: 29882783
[TBL] [Abstract][Full Text] [Related]
35. The inhibition by flavonoids of 2-amino-3-methylimidazo[4,5-f]quinoline metabolic activation to a mutagen: a structure-activity relationship study.
Edenharder R; Rauscher R; Platt KL
Mutat Res; 1997 Sep; 379(1):21-32. PubMed ID: 9330619
[TBL] [Abstract][Full Text] [Related]
36. In silico investigation of lavandulyl flavonoids for the development of potent fatty acid synthase-inhibitory prototypes.
Oh J; Liu H; Park HB; Ferreira D; Jeong GS; Hamann MT; Doerksen RJ; Na M
Biochim Biophys Acta Gen Subj; 2017 Jan; 1861(1 Pt A):3180-3188. PubMed ID: 27531709
[TBL] [Abstract][Full Text] [Related]
37. Inhibitory effect of flavonoids on human glutaminyl cyclase.
Li M; Dong Y; Yu X; Zou Y; Zheng Y; Bu X; Quan J; He Z; Wu H
Bioorg Med Chem; 2016 May; 24(10):2280-6. PubMed ID: 27061673
[TBL] [Abstract][Full Text] [Related]
38. From Myricetin to the Discovery of Novel Natural Human ENPP1 Inhibitors: A Virtual Screening, Molecular Docking, Molecular Dynamics Simulation, and MM/GBSA Study.
Song S; Shao Z
Molecules; 2022 Sep; 27(19):. PubMed ID: 36234712
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of 7-ethoxycoumarin O-deethylase activity in rat liver microsomes by naturally occurring flavonoids: structure-activity relationships.
Moon JY; Lee DW; Park KH
Xenobiotica; 1998 Feb; 28(2):117-26. PubMed ID: 9522437
[TBL] [Abstract][Full Text] [Related]
40. Anti-Neurodegenerating Activity: Structure-Activity Relationship Analysis of Flavonoids.
Preet G; Haj Hasan A; Ramlagan P; Fawdar S; Boulle F; Jaspars M
Molecules; 2023 Oct; 28(20):. PubMed ID: 37894669
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
